Brazil, Mexico access to expensive cancer drugs "improving"

Article Date: 12/04/2012 06:00
Brazil, Mexico access to expensive cancer drugs "improving"

Vacancy Search

Quick job search

Advanced Search

Latest News

GW tests cannabinoid drug in PhIII epilepsy trial

GW tests cannabinoid drug in PhIII epilepsy trial

Merck and Syndax form immuno-oncology pact

Merck and Syndax form immuno-oncology pact

UK new meds uptake still a "major issue"

UK new meds uptake still a "major issue"

Teva bolsters CNS offering with $3.5bn Auspex buy

Teva bolsters CNS offering with $3.5bn Auspex buy

Novartis' Zykadia clears first step in UK early access scheme

Novartis' Zykadia clears first step in UK early access scheme

Merck Serono and Intrexon sign $941m CAR-T deal

Merck Serono and Intrexon sign $941m CAR-T deal

Speedy US review for Amgen's Kyprolis

Speedy US review for Amgen's Kyprolis

Novartis in $250m cancer immunotherapy pact with Aduro

Novartis in $250m cancer immunotherapy pact with Aduro

EU to review Biogen/AbbVie's once-monthly MS jab

EU to review Biogen/AbbVie's once-monthly MS jab

UK biotech consortium wins £6.2m AMSCI grant

UK biotech consortium wins £6.2m AMSCI grant
more news